New gentler transplant approach aims to cure devastating blood diseases
NCT ID NCT03980769
Summary
This study is testing a stem cell transplant procedure that uses a less intense combination of drugs to prepare patients for the transplant. The goal is to cure serious non-cancerous blood and immune system disorders in patients under 50 years old by replacing their faulty bone marrow with healthy donor cells. Researchers hope this new drug regimen will be as effective as standard, more toxic treatments but with fewer severe side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fred Hutch/University of Washington Cancer Consortium
RECRUITINGSeattle, Washington, 98109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.